Chang, Y.; Li, J.-Y.; Jayakumar, T.; Hung, S.-H.; Lee, W.-C.; Manubolu, M.; Sheu, J.-R.; Hsu, M.-J.
Ketamine, a Clinically Used Anesthetic, Inhibits Vascular Smooth Muscle Cell Proliferation via PP2A-Activated PI3K/Akt/ERK Inhibition. Int. J. Mol. Sci. 2017, 18, 2545.
https://doi.org/10.3390/ijms18122545
AMA Style
Chang Y, Li J-Y, Jayakumar T, Hung S-H, Lee W-C, Manubolu M, Sheu J-R, Hsu M-J.
Ketamine, a Clinically Used Anesthetic, Inhibits Vascular Smooth Muscle Cell Proliferation via PP2A-Activated PI3K/Akt/ERK Inhibition. International Journal of Molecular Sciences. 2017; 18(12):2545.
https://doi.org/10.3390/ijms18122545
Chicago/Turabian Style
Chang, Yi, Jiun-Yi Li, Thanasekaran Jayakumar, Shou-Huang Hung, Wei-Cheng Lee, Manjunath Manubolu, Joen-Rong Sheu, and Ming-Jen Hsu.
2017. "Ketamine, a Clinically Used Anesthetic, Inhibits Vascular Smooth Muscle Cell Proliferation via PP2A-Activated PI3K/Akt/ERK Inhibition" International Journal of Molecular Sciences 18, no. 12: 2545.
https://doi.org/10.3390/ijms18122545
APA Style
Chang, Y., Li, J.-Y., Jayakumar, T., Hung, S.-H., Lee, W.-C., Manubolu, M., Sheu, J.-R., & Hsu, M.-J.
(2017). Ketamine, a Clinically Used Anesthetic, Inhibits Vascular Smooth Muscle Cell Proliferation via PP2A-Activated PI3K/Akt/ERK Inhibition. International Journal of Molecular Sciences, 18(12), 2545.
https://doi.org/10.3390/ijms18122545